Occudo Quantitative Strategies LP bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought 16,945 shares of the company’s stock, valued at approximately $672,000.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Lindbrook Capital LLC raised its position in shares of Acadia Healthcare by 1,342.0% during the fourth quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock worth $29,000 after purchasing an additional 671 shares during the period. Blue Trust Inc. raised its holdings in Acadia Healthcare by 69.4% during the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock worth $33,000 after buying an additional 345 shares during the period. Nisa Investment Advisors LLC lifted its stake in Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after buying an additional 301 shares in the last quarter. Signaturefd LLC boosted its holdings in shares of Acadia Healthcare by 460.6% in the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock valued at $48,000 after buying an additional 1,004 shares during the period. Finally, Quadrant Capital Group LLC raised its holdings in shares of Acadia Healthcare by 287.1% during the fourth quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company’s stock worth $50,000 after acquiring an additional 933 shares during the period.
Analyst Upgrades and Downgrades
ACHC has been the subject of a number of research analyst reports. Guggenheim started coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They issued a “buy” rating and a $36.00 target price for the company. Mizuho lowered their price objective on shares of Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating on the stock in a report on Wednesday. Barclays reduced their target price on shares of Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating for the company in a report on Wednesday. Royal Bank of Canada decreased their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a research report on Monday, March 3rd. Finally, KeyCorp reduced their price objective on shares of Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating for the company in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $47.94.
Acadia Healthcare Trading Down 4.5%
Shares of Acadia Healthcare stock opened at $25.72 on Thursday. Acadia Healthcare Company, Inc. has a 52-week low of $20.36 and a 52-week high of $82.41. The stock has a market cap of $2.37 billion, a PE ratio of 8.43, a PEG ratio of 1.46 and a beta of 1.01. The firm has a 50-day moving average of $26.34 and a 200-day moving average of $36.01. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. During the same quarter in the prior year, the business posted $0.84 EPS. The business’s revenue was up .3% compared to the same quarter last year. As a group, sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Recommended Stories
- Five stocks we like better than Acadia Healthcare
- What Are Growth Stocks and Investing in Them
- SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start
- What Investors Need to Know About Upcoming IPOs
- AMD’s AI-Powered Stock Price Rally Just Shifted Gears
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- 5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.